Tectonic Therapeutic, Inc.
TECX
$21.09
-$1.29-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.12% | 22.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.75% | 71.94% | |||
| Operating Income | 28.75% | -71.94% | |||
| Income Before Tax | 30.16% | -39.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.16% | -39.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.16% | -39.82% | |||
| EBIT | 28.75% | -71.94% | |||
| EBITDA | 29.82% | -73.32% | |||
| EPS Basic | 30.47% | 72.28% | |||
| Normalized Basic EPS | 30.46% | 72.28% | |||
| EPS Diluted | 30.47% | 72.28% | |||
| Normalized Diluted EPS | 30.46% | 72.28% | |||
| Average Basic Shares Outstanding | 0.43% | 404.44% | |||
| Average Diluted Shares Outstanding | 0.43% | 404.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||